TEVA PHARMACEUTICAL INDUSTRIES (TEVA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
TEVA PHARMACEUTICAL INDUSTRIES insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 14 sold $113M of TEVA stock on the open market.
Get emailed when insiders cluster-buy stocks like TEVA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TEVA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $17.0M | 11 |
| Q2 2026 | — | 0 | $18.9M | 11 |
| Q1 2026 | — | 0 | $57.2M | 26 |
| Q4 2025 | — | 0 | $20.1M | 10 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 TEVA PHARMACEUTICAL INDUSTRIES LTD insiders reported open-market purchases totaling $0, while 14 insiders reported sales totaling $113M. 31 of 58 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Members of Congress who traded TEVA
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 30, 2026 | Jul 21, 2026 | +45.0% |
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 22SEC | Roberto MignoneDirector | Sell | 367,600 | $39.06 | $14.4M | +5.2% | — |
| Sep 22SEC | Brian SavageGeneral Counsel | Sell | 4,50311,339 held (−28%) | $38.69 | $174K | +6.2% | — |
| Sep 22SEC | Brian SavageGeneral Counsel | Sell | 2,5258,814 held (−22%) | $39.15 | $99K | +5.0% | — |
| Sep 22SEC | Brian SavageGeneral Counsel | Sell | 3148,500 held (−4%) | $38.70 | $12K | +6.2% | — |
| Aug 25SEC | Amir WeissChief Accounting Officer | Sell | 6,94513,071 held (−35%) | $37.61 | $261K | +9.3% | — |
| Aug 25SEC | Amir WeissChief Accounting Officer | Sell | 2,50013,071 held (−16%) | $37.63 | $94K | +9.2% | — |
| Aug 25SEC | Ronit Satchi-fainaroDirector | Sell | 415111,986 held (−0%) | $37.25 | $15K | +10.3% | — |
| Aug 19SEC | Evan LippmanEvp, Business Development | Sell Plan | 18,60025,591 held (−42%) | $36.57 | $680K | +12.4% | — |
| Aug 10SEC | Tal Zvi ZaksDirector | Sell | 1773,247 held (−0%) | $34.87 | $593 | +17.9% | — |
| Aug 5SEC | Eric A Hughes"See ""Remarks""" | Sell Plan | 25,578134,877 held (−16%) | $34.88 | $892K | +17.8% | — |
| Aug 5SEC | Placid Jover"See ""Remarks""" | Sell Plan | 12,8276,774 held (−65%) | $34.88 | $447K | +17.8% | — |
| Jun 22SEC | Matthew ShieldsEvp, Global Operations | Sell | 9,989 | $32.19 | $322K | +27.7% | — |
| Jun 16SEC | Eliyahu Sharon KalifCFO | Sell Plan | 106,56365,621 held (−62%) | $34.10 | $3.6M | +20.5% | — |
| Jun 8SEC | Richard D FrancisCEO, President | Sell Plan | 6,1531,177,529 held (−1%) | $34.35 | $211K | +19.7% | — |
| Jun 4SEC | Matthew ShieldsEvp, Global Operations | Sell Plan | 16,1959,989 held (−62%) | $32.87 | $532K | +25.0% | — |
| May 18SEC | Eliyahu Sharon KalifCFO | Sell Plan | 153,251172,184 held (−47%) | $35.61 | $5.5M | +15.4% | — |
| May 18SEC | Evan LippmanEvp, Business Development | Sell Plan | 35,91244,191 held (−45%) | $35.58 | $1.3M | +15.5% | — |
| May 18SEC | Evan LippmanEvp, Business Development | Sell Plan | 5,7466,095 held (−49%) | $35.58 | $204K | +15.5% | — |
| May 7SEC | Richard DaniellEvp, Europe Commercial | Sell | 30,00055,755 held (−35%) | $35.40 | $1.1M | +16.1% | — |
| May 7SEC | Amir WeissChief Accounting Officer | Sell | 10,67920,016 held (−35%) | $36.00 | $384K | +14.2% | — |
| May 4SEC | Mark Sabag"See ""Remarks""" | Sell | 144,18080,760 held (−64%) | $34.99 | $5.0M | +17.5% | — |
| May 4SEC | Christine FoxEvp, U.S. Commercial | Sell | 21,25863,647 held (−25%) | $35.31 | $751K | +16.4% | — |
| Mar 19SEC | Mark Sabag"See ""Remarks""" | Sell | 62,102224,940 held (−22%) | $30.14 | $1.9M | +36.4% | — |
| Mar 9SEC | Richard D FrancisCEO, President | Sell Plan | 20,0251,170,639 held (−2%) | $31.67 | $634K | +29.8% | — |
| Mar 9SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 17,29585,755 held (−17%) | $31.67 | $548K | +29.8% | — |
| Mar 9SEC | Matthew ShieldsEvp, Global Operations | Sell Plan | 17,2959,989 held (−63%) | $31.67 | $548K | +29.8% | — |
| Mar 9SEC | Placid Jover"See ""Remarks""" | Sell Plan | 14,1506,774 held (−68%) | $31.67 | $448K | +29.8% | — |
| Mar 9SEC | Eric A Hughes"See ""Remarks""" | Sell Plan | 9,533107,711 held (−8%) | $31.67 | $302K | +29.8% | — |
| Mar 9SEC | Christine FoxEvp, U.S. Commercial | Sell Plan | 7,92484,905 held (−9%) | $31.67 | $251K | +29.8% | — |
| Mar 9SEC | Brian SavageGeneral Counsel | Sell | 1,12710,914 held (−9%) | $31.67 | $36K | +29.8% | — |
| Mar 6SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 37,37285,755 held (−30%) | $32.95 | $1.2M | +24.7% | — |
| Mar 6SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 33,512123,127 held (−21%) | $32.46 | $1.1M | +26.6% | — |
| Mar 6SEC | Richard D FrancisCEO, President | Sell Plan | 23,3931,148,212 held (−2%) | $32.46 | $759K | +26.6% | — |
| Mar 6SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 20,461123,127 held (−14%) | $32.46 | $664K | +26.6% | — |
| Mar 6SEC | Eric A Hughes"See ""Remarks""" | Sell Plan | 11,27797,590 held (−10%) | $32.46 | $366K | +26.6% | — |
| Mar 6SEC | Christine FoxEvp, U.S. Commercial | Sell Plan | 9,09875,010 held (−11%) | $32.46 | $295K | +26.6% | — |
| Mar 6SEC | Brian SavageGeneral Counsel | Sell | 1,4896,181 held (−19%) | $32.46 | $48K | +26.6% | — |
| Mar 6SEC | Brian SavageGeneral Counsel | Sell | 1,1868,461 held (−12%) | $32.46 | $38K | +26.6% | — |
| Mar 5SEC | Richard D FrancisCEO, President | Sell Plan | 412,0321,121,382 held (−27%) | $32.36 | $13.3M | +27.0% | — |
| Mar 5SEC | Eric A Hughes"See ""Remarks""" | Sell Plan | 68,68585,616 held (−45%) | $32.36 | $2.2M | +27.0% | — |
| Mar 5SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 66,735123,127 held (−35%) | $32.36 | $2.2M | +27.0% | — |
| Mar 5SEC | Richard DaniellEvp, Europe Commercial | Sell Plan | 62,25048,384 held (−56%) | $32.36 | $2.0M | +27.0% | — |
| Mar 5SEC | Richard D FrancisCEO, President | Sell Plan | 30,903642,099 held (−5%) | $32.36 | $1.0M | +27.0% | — |
| Mar 5SEC | Eric A Hughes"See ""Remarks""" | Sell Plan | 12,07712,823 held (−49%) | $32.36 | $391K | +27.0% | — |
| Mar 5SEC | Brian SavageGeneral Counsel | Sell | 1,2742,926 held (−30%) | $32.36 | $41K | +27.0% | — |
| Mar 2SEC | Eliyahu Sharon KalifCFO | Sell Plan | 345,81057,478 held (−86%) | $33.64 | $11.6M | +22.2% | — |
| Feb 18SEC | Richard D FrancisCEO, President | Sell Plan | 286,122605,771 held (−32%) | $34.22 | $9.8M | +20.1% | — |
| Feb 18SEC | Richard D FrancisCEO, President | Sell Plan | 161,656271,783 held (−37%) | $34.22 | $5.5M | +20.1% | — |
| Dec 18SEC | Roberto MignoneDirector | Sell | 77,400367,600 held (−17%) | $30.24 | $2.3M | +35.9% | — |
| Dec 18SEC | Amir WeissChief Accounting Officer | Sell | 12,3005,650 held (−69%) | $30.20 | $371K | +36.1% | — |
| Dec 11SEC | Mark Sabag"See ""Remarks""" | Sell | 118,724150,996 held (−44%) | $28.75 | $3.4M | +43.0% | — |
| Dec 11SEC | Richard DaniellExec. Vp, European Commercial | Sell | 115,46848,384 held (−70%) | $28.68 | $3.3M | +43.3% | — |
| Dec 11SEC | Mark Sabag"See ""Remarks""" | Sell | 98,16852,828 held (−65%) | $28.70 | $2.8M | +43.2% | — |
| Dec 1SEC | Roberto MignoneDirector | Sell | 50,000445,000 held (−10%) | $26.03 | $1.3M | +57.9% | — |
| Nov 24SEC | Christine FoxEvp, Head Of U.S. Commercial | Sell Plan | 28,22963,647 held (−31%) | $24.78 | $700K | +65.9% | — |
| Nov 18SEC | Christine FoxEvp, Head Of U.S. Commercial | Sell | 30,00028,384 held (−51%) | $25.11 | $753K | +63.7% | — |
| Nov 10SEC | Roberto MignoneDirector | Sell | 200,000495,000 held (−29%) | $24.11 | $4.8M | +70.5% | — |
| Nov 10SEC | Amir WeissChief Accounting Officer | Sell | 12,30017,950 held (−41%) | $24.44 | $301K | +68.2% | — |
Insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Richard D FrancisCEO, President | — | $31.3M | Jun 8, 2026 | — |
| Roberto MignoneDirector | — | $22.8M | Sep 22, 2026 | — |
| Eliyahu Sharon KalifCFO | — | $20.7M | Jun 16, 2026 | — |
| Mark Sabag"See ""Remarks""" | — | $13.1M | May 4, 2026 | — |
| Richard DaniellEvp, Europe Commercial | — | $12.1M | May 7, 2026 | — |
| Eric A Hughes"See ""Remarks""" | — | $4.2M | Aug 5, 2026 | — |
| Christine FoxEvp, U.S. Commercial | — | $2.7M | May 4, 2026 | — |
| Evan LippmanEvp, Business Development | — | $2.2M | Aug 19, 2026 | — |
| Amir WeissChief Accounting Officer | — | $1.4M | Aug 25, 2026 | — |
| Matthew ShieldsEvp, Global Operations | — | $1.4M | Jun 22, 2026 | — |
| Placid Jover"See ""Remarks""" | — | $896K | Aug 5, 2026 | — |
| Brian SavageGeneral Counsel | — | $449K | Sep 22, 2026 | — |
| Ronit Satchi-fainaroDirector | — | $15K | Aug 25, 2026 | — |
| Tal Zvi ZaksDirector | — | $593 | Aug 10, 2026 | — |
TEVA stock: common questions
Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders buying TEVA stock?
In the past 12 months, 0 insiders reported open-market purchases of TEVA worth $0.
Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders selling TEVA stock?
14 insiders reported sales worth $113M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TEVA's 52-week range?
Over the past year TEVA has traded between $18.95 and $41.10. It last closed at $41.10 on Oct 9, 2026.